Latest: Novel technology in non-invasive 3D ex vivo imaging and cultivation platforms
Latest: The promise of proteomics: Transforming healthcare from treatment to disease prevention
Latest: From tiny particles to big success: KNAUER awarded the Innovation Prize for Berlin...
Latest: Waters and Sartorius partner to help bioprocess scientists accelerate clone selection...
Latest: QuPPe method now includes an approach using Restek’s Raptor Polar X LC Column for...
Latest: ‘Lab product reviews are an invaluable companion to my research’
Latest: Powerful new semiconductor tool introduced by Park Systems combines atomic force...
‘Lab product reviews are an invaluable companion to my research’
The promise of proteomics: Transforming healthcare from treatment to disease prevention
Seegene's high multiplex PCR assay capable of detecting new Omicron variant
VIASURE Kits can detect the new Omicron SARS-CoV-2 variant
Redefining bioseparations science with MaxPeak Premier Solutions
Novel technology in non-invasive 3D ex vivo imaging and cultivation platforms
A guide to efficient and greener cannabinoid purification
Increasing LC-MS accessibility for streamlined biotherapeutic analysis
Immtox 270 Brochure
Moderate/Highly Complex Test Menu
Reliably purify nucleic acids from respiratory pathogens across a broad concentration range
Automate RNA purification for high-throughput processing of 2019-nCoV samples
Biophysical Characterization Technology
How to buy next-generation sequencing
Virtual Clinical Science Summit
Virtual Cancer & Immunology Research Summit
05 Feb 22 - 09 Feb 22
Analytical Science Summit...
14 Feb 22 - 15 Feb 22
NEW: Infectious Disease &...
01 Mar 22 - 07 Mar 22
04 Apr 22 - 08 Apr 22
09 May 22 - 13 May 22
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have provided an update on the MOVe-OUT study of molnupiravir (MK-4482, EIDD-2801), an investi...Read Full ArticleDiane Li